jueves, 28 de junio de 2018

Carbohydrate status in patients with phenylketonuria | Orphanet Journal of Rare Diseases | Full Text

Carbohydrate status in patients with phenylketonuria | Orphanet Journal of Rare Diseases | Full Text

Orphanet Journal of Rare Diseases

Carbohydrate status in patients with phenylketonuria

  • María L. CouceEmail authorView ORCID ID profile,
  • Paula Sánchez-Pintos,
  • Isidro Vitoria,
  • María-José De Castro,
  • Luís Aldámiz-Echevarría,
  • Patricia Correcher,
  • Ana Fernández-Marmiesse,
  • Iria Roca,
  • Alvaro Hermida,
  • Miguel Martínez-Olmos and
  • Rosaura Leis
Orphanet Journal of Rare Diseases201813:103
Received: 26 February 2018
Accepted: 20 June 2018
Published: 27 June 2018



In patients with phenylketonuria (PKU), a low-phenylalanine (Phe) diet supplemented with low-protein foods and a Phe-free amino acid mixture favors a dietary intake rich in carbohydrates, but little is known about how these molecules are metabolized in this setting. The objective of the present study was to analyze carbohydrate metabolism in patients with hyperphenylalaninemia.


We conducted a multicenter cross-sectional study to investigate biochemical markers of basal and postprandial carbohydrate metabolism in PKU patients according to age, Phe tolerance, waist circumference and body mass index (BMI), diet, tetrahydrobiopterin (BH4) supplementation, and adherence to treatment. Basal biomarkers and anthropometric parameters were also evaluated in patients with mild hyperphenylalaninemia (MHPA) and in healthy controls.


A total of 83 patients aged 4–52 years were studied; 68.7% had PKU and 31.3% had MHPA. 68 healthy controls of similar sex and age were also evaluated Metabolic control was adequate in 71.9% of PKU patients. Fasting glucose levels (mean 80.77 ± 8.06 mg/dL) were high in just one patient, but fasting insulin levels, with a mean of 12.74 ± 8.4 mIU/L, were altered in 15 PKU patients (26.3%) and markedly higher than in patients with MPHA (p = 0.035). Fasting insulin levels and Homeostasis Model Assessment Insulin Resistance (HOMA-IR) were significantly higher than in healthy controls and correlated with body mass index, waist circumference, age, and also showed statistically significant differences according to diagnosis and Phe tolerance (p < 0.05). Patients under BH4 therapy had lower insulin levels and HOMA-IR. A higher mean carbohydrate intake from AA mixtures was observed in classic PKU patients. The caloric intake in the form of carbohydrates was also higher in PKU than MHPA patients (p = 0.038) and it was correlated with basal insulin (rho = 0.468, p = 0.006), HOMA-IR (rho = 0.423, p = 0.02), BMI (rho 0.533, p = 0.002), and waist circumference (rho 0.584, p = 0.0007).


This study shows that PKU patients are at risk of carbohydrate intolerance and insulin resistance, more evident in adults and overweight patients, probably related to their higher caloric intake in form carbohydrate content. A higher dependency of AA mixtures was demonstrated in PKU patients.


HOMA indexInsulinNutritionPhenylalanineTetrahydrobiopterin

No hay comentarios:

Publicar un comentario